INCOME TAXES	6 Months Ended
Jun. 30, 2013
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The federal research and development tax credit was extended by the signing of the American Taxpayer Relief Act of 2012 (“Act”) on January 2, 2013. The Act retroactively extended this tax credit from January 1, 2012 through December 31, 2013. Since the Act was enacted during 2013, the income tax benefit related to the federal 2012 research and development tax credit resulted in a $0.8 million reduction of income tax expense for the six months ended June 30, 2013. As disclosed in Note 14 of the 2012 Form 10-K, the Company was notified in 2010 by the Internal Revenue Service (“IRS”) of its intention to examine the 2006 federal income tax return related to certain transfer pricing tax positions. This examination was subsequently extended to include the 2007 — 2011 federal income tax returns. In April 2013, the Company reached a settlement to conclude the IRS examination that increased US taxable income and resulted in additional taxes payable of $3.1 million for the cumulative 2006 – 2011 tax years. As a result of this settlement, the Company also reversed reserves for uncertain tax positions related to these years. The net effect of the settlement was a net income tax benefit of $10 million in the second quarter of 2013.

INCOME TAXES

6 Months Ended

Jun. 30, 2013

The federal research and development tax credit was extended by the signing of the American Taxpayer Relief Act of 2012 (“Act”) on January 2, 2013. The Act retroactively extended this tax credit from January 1, 2012 through December 31, 2013. Since the Act was enacted during 2013, the income tax benefit related to the federal 2012 research and development tax credit resulted in a $0.8 million reduction of income tax expense for the six months ended June 30, 2013.

As disclosed in Note 14 of the 2012 Form 10-K, the Company was notified in 2010 by the Internal Revenue Service (“IRS”) of its intention to examine the 2006 federal income tax return related to certain transfer pricing tax positions. This examination was subsequently extended to include the 2007 — 2011 federal income tax returns. In April 2013, the Company reached a settlement to conclude the IRS examination that increased US taxable income and resulted in additional taxes payable of $3.1 million for the cumulative 2006 – 2011 tax years. As a result of this settlement, the Company also reversed reserves for uncertain tax positions related to these years. The net effect of the settlement was a net income tax benefit of $10 million in the second quarter of 2013.